Document Type
Article
Journal Title
Tropical Diseases, Travel Medicine and Vaccines
Publication Date
2016
Volume
2
Abstract
The HIV pandemic persists globally and travelers are at risk for infection by the Human Immunodeficiency Virus (HIV). While HIV-focused guidelines delineate risk stratification and mitigation strategies for people in their home communities, travel issues are not addressed. In this review, direct and indirect evidence on HIV risk among travelers is explored. The burgeoning practice of employing pre-exposure prophylaxis (PrEP) with anti-retroviral therapy in the non-travel setting is introduced, as well as the more established use of post-exposure prophylaxis (PEP). Challenges in applying these lessons to travelers are discussed, and a new guidelines process is scoped and recommended.
DOI Link
ISSN
2055-0936
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Recommended Citation
Brett-Major, David; Scott, P. T.; Crowell, T A.; Polyak, C. S.; Modjarrad, K.; Robb, M. L.; and Blazes, D. L., "Are You PEPped and PrEPped for Travel? Risk Mitigation of HIV Infection for Travelers" (2016). Journal Articles: Epidemiology. 14.
https://digitalcommons.unmc.edu/coph_epidem_articles/14